Climb Bio Q2 EPS $(0.18) Beats $(0.21) Estimate
Benzinga Newsdesk 2 months ago
NewsEarningsEarnings Beats
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 38.46 percent decrease over losses of $(0.13) per share from the
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 38.46 percent decrease over losses of $(0.13) per share from the same period last year.